van Oortmerssen Julie A E, Mulder Janneke W C M, Kavousi Maryam, Roeters van Lennep Jeanine E
Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Internal Medicine, Erasmus MC Cardiovascular Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Atherosclerosis. 2025 Jun;405:119213. doi: 10.1016/j.atherosclerosis.2025.119213. Epub 2025 Apr 24.
The menopausal transition, defined by the cessation of menstruation due to declining ovarian follicular function, results in a marked decrease in endogenous estrogen levels. This phase is associated with significant metabolic changes and a shift towards a more atherogenic lipid profile. Specifically, there are increases in total cholesterol, low-density lipoprotein cholesterol, and triglycerides and unfavorable alterations in high-density lipoprotein cholesterol and lipoprotein(a) levels. These lipid changes, which contribute to an increased risk of atherosclerotic cardiovascular disease, are influenced by diminished estrogen levels and chronological aging. However, the specific mechanisms driving this increased risk are not fully understood. A thorough understanding of these lipid profile alterations is important for developing strategies to reduce cardiovascular disease risk in women. This review provides an overview of how lipid metabolism is affected during the menopausal transition and the resulting implications for cardiovascular risk.
围绝经期过渡,定义为由于卵巢卵泡功能下降导致月经停止,会使内源性雌激素水平显著降低。这一阶段与显著的代谢变化以及向更易致动脉粥样硬化的血脂谱转变有关。具体而言,总胆固醇、低密度脂蛋白胆固醇和甘油三酯增加,高密度脂蛋白胆固醇和脂蛋白(a)水平出现不利变化。这些导致动脉粥样硬化性心血管疾病风险增加的血脂变化,受雌激素水平降低和自然衰老的影响。然而,导致这种风险增加的具体机制尚未完全明确。深入了解这些血脂谱改变对于制定降低女性心血管疾病风险的策略至关重要。本综述概述了围绝经期过渡期间脂质代谢如何受到影响以及对心血管风险的影响。